Yayınlar & Eserler

Yayın Ağı
Makaleler 12
Tümü (12)
SCI-E, SSCI, AHCI (10)
SCI-E, SSCI, AHCI, ESCI (12)
ESCI (2)
Scopus (11)
TRDizin (1)

1. Comparison of the characteristics of patients with chronic urticaria receiving standard-or high-dose omalizumab

TUNCAY G., DAMADOĞLU E., KARAKAYA G., KALYONCU A. F.
European Annals of Allergy and Clinical Immunology , cilt.58, sa.2, ss.69-76, 2026 (ESCI, Scopus) Creative Commons License identifier identifier

2. Comparison of the Efficacy of Omalizumab and Mepolizumab in Non-Steroidal Anti-Inflammatory Drug-Exacerbated Respiratory Disease

CİHANBEYLERDEN M., TUNCAY G., KAYIKÇI H., DAMADOĞLU E., KARAKAYA G., KALYONCU A. F.
INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY , cilt.185, ss.947-952, 2024 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier identifier

3. Efficacy and safety of hymenoptera venom immunotherapy

KAYIKÇI H., Bostan O. C., TUNCAY G., CİHANBEYLERDEN M., DAMADOĞLU E., KARAKAYA G., et al.
ALLERGY AND ASTHMA PROCEEDINGS , cilt.45, sa.4, ss.268-275, 2024 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier identifier

4. Successful desensitization in a patient with recurrent anaplastic oligodendroglioma presenting with procarbazine-mediated anaphylaxis

KAYIKÇI H., Can Bostan Ö., TUNCAY G., CİHANBEYLERDEN M., Tüccar Ç., DAMADOĞLU E., et al.
Journal of Oncology Pharmacy Practice , 2024 (SCI-Expanded, Scopus) identifier identifier identifier

5. Urticaria exacerbations and adverse reactions in patients with chronic urticaria receiving COVID-19 vaccination: Results of the UCARE COVAC-CU study

Kocatürk E., Salameh P., Sarac E., Vera Ayala C. E., Thomsen S. F., Zuberbier T., et al.
Journal of Allergy and Clinical Immunology , cilt.152, sa.5, ss.1095-1106, 2023 (SCI-Expanded, Scopus) identifier identifier identifier

6. Evaluation of disease control after SARS-CoV-2 infection or vaccination in patients with NSAID-exacerbated airway disease

CİHANBEYLERDEN M., CAN BOSTAN Ö., TUNCAY G., Safak C., DAMADOĞLU E., KARAKAYA G., et al.
Allergy and asthma proceedings , cilt.44, sa.4, 2023 (SCI-Expanded, Scopus) identifier identifier identifier

7. SARS-CoV-2 vaccines are well tolerated in patients with mastocytosis

TUNCAY G., CAN BOSTAN Ö., DAMADOĞLU E., KARAKAYA G., KALYONCU A. F.
Annals of Allergy, Asthma and Immunology , cilt.128, sa.6, ss.733-734, 2022 (SCI-Expanded, Scopus) Creative Commons License identifier identifier identifier

8. SARS-CoV-2 vaccines are well tolerated in patients with mastocytosis

TUNCAY G., CAN BOSTAN Ö., KARAKAYA G., KALYONCU A. F.
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY , cilt.128, sa.6, ss.733-734, 2022 (SCI-Expanded, Scopus) identifier

9. The association of timothy grass allergy and cat ownership on cat sensitization

CAN BOSTAN Ö., Cakmak M. E., Kaya S. B., TUNCAY G., DAMADOĞLU E., KARAKAYA G., et al.
ALLERGY AND ASTHMA PROCEEDINGS , cilt.43, sa.3, ss.220-225, 2022 (SCI-Expanded, Scopus) identifier identifier identifier

10. The course of COVID-19 in patients with severe asthma receiving biological treatment

TUNCAY G., Cakmak M. E., CAN BOSTAN Ö., KAYA S. B., DAMADOĞLU E., KARAKAYA G., et al.
JOURNAL OF ASTHMA , cilt.59, sa.11, ss.2174-2180, 2022 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier identifier

11. Effect of COVID-19 on hereditary angioedema activity and quality of life

CAN BOSTAN Ö., TUNCAY G., DAMADOĞLU E., KARAKAYA G., KALYONCU A. F.
ALLERGY AND ASTHMA PROCEEDINGS , cilt.42, sa.5, ss.403-408, 2021 (SCI-Expanded, Scopus) identifier identifier identifier

12. Mortality due to COVID-19 in a Patient with Severe Asthma Receiving Omalizumab Treatment: A Case Report

Cakmak M. E., KAYA S. B., CAN BOSTAN Ö., TUNCAY G., DAMADOĞLU E., KARAKAYA G., et al.
ASTIM ALLERJI IMMUNOLOJI , cilt.18, ss.27-29, 2020 (ESCI, TRDizin) Sürdürülebilir Kalkınma identifier
Metrikler

Yayın

12

Yayın (WoS)

12

Yayın (Scopus)

11

Atıf (WoS)

17

H-İndeks (WoS)

3

Atıf (Scopus)

18

H-İndeks (Scopus)

2

Açık Erişim

2
BM Sürdürülebilir Kalkınma Amaçları